These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 8162565
1. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA. Cancer Res; 1994 May 01; 54(9):2287-91. PubMed ID: 8162565 [Abstract] [Full Text] [Related]
2. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA. Cancer Gene Ther; 1994 Mar 01; 1(1):5-13. PubMed ID: 7621238 [Abstract] [Full Text] [Related]
3. Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer. Miyake H, Hara I, Gohji K, Yamanaka K, Arakawa S, Kamidono S. Anticancer Res; 1998 Mar 01; 18(4C):3087-92. PubMed ID: 9713515 [Abstract] [Full Text] [Related]
4. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism. Riva CM. Anticancer Res; 2000 Mar 01; 20(6B):4463-71. PubMed ID: 11205289 [Abstract] [Full Text] [Related]
5. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells. Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N. Oncogene; 1999 Apr 01; 18(13):2189-99. PubMed ID: 10327065 [Abstract] [Full Text] [Related]
6. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Nguyen DM, Wiehle SA, Koch PE, Branch C, Yen N, Roth JA, Cristiano RJ. Cancer Gene Ther; 1997 Apr 01; 4(3):191-8. PubMed ID: 9171938 [Abstract] [Full Text] [Related]
7. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells. Ling YH, Zou Y, Perez-Soler R. Anticancer Res; 2000 Apr 01; 20(2A):693-702. PubMed ID: 10810342 [Abstract] [Full Text] [Related]
8. Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells. Horio Y, Hasegawa Y, Sekido Y, Takahashi M, Roth JA, Shimokata K. Cancer Gene Ther; 2000 Apr 01; 7(4):537-44. PubMed ID: 10811471 [Abstract] [Full Text] [Related]
9. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients. Boulay JL, Perruchoud AP, Reuter J, Bolliger C, Herrmann R, Rochlitz C. Cancer Gene Ther; 2000 Sep 01; 7(9):1215-9. PubMed ID: 11023193 [Abstract] [Full Text] [Related]
10. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis. Gu J, Zhang L, Swisher SG, Liu J, Roth JA, Fang B. Oncogene; 2004 Feb 12; 23(6):1300-7. PubMed ID: 14676844 [Abstract] [Full Text] [Related]
11. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA, Ramesh R. Gene Ther; 2000 Dec 12; 7(23):2051-7. PubMed ID: 11175318 [Abstract] [Full Text] [Related]
12. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Nielsen LL, Dell J, Maxwell E, Armstrong L, Maneval D, Catino JJ. Cancer Gene Ther; 1997 Dec 12; 4(2):129-38. PubMed ID: 9080122 [Abstract] [Full Text] [Related]
13. P53-independent thermosensitization by mitomycin C in human non-small-cell lung cancer cells. Jin ZH, Matsumoto H, Hayashi S, Hatashita M, Ohtsubo T, Shioura H, Kitai R, Kano E. Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):852-60. PubMed ID: 15183489 [Abstract] [Full Text] [Related]
14. E1B-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence of apoptosis. Harada N, Maniwa Y, Yoshimura M, Nagata M, Hamada H, Yokono K, Okita Y. Oncol Rep; 2005 Nov 01; 14(5):1155-63. PubMed ID: 16211279 [Abstract] [Full Text] [Related]
15. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line]. Wang H, Lai B, Li J. Zhonghua Jie He He Hu Xi Za Zhi; 1998 May 01; 21(5):268-72. PubMed ID: 11326947 [Abstract] [Full Text] [Related]
16. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer. Li PX, Ngo D, Brade AM, Klamut HJ. Cancer Gene Ther; 1999 May 01; 6(2):179-90. PubMed ID: 10195885 [Abstract] [Full Text] [Related]
17. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation. Shono T, Tofilon PJ, Schaefer TS, Parikh D, Liu TJ, Lang FF. Cancer Res; 2002 Feb 15; 62(4):1069-76. PubMed ID: 11861384 [Abstract] [Full Text] [Related]
18. [Molecular therapy for human cancer with tumor suppressor p53 gene transfer]. Fujiwara T, Inoue F, Tanaka N. Gan To Kagaku Ryoho; 1998 Jan 15; 25(2):194-200. PubMed ID: 9474928 [Abstract] [Full Text] [Related]
19. Cell cycle arrest is sufficient for p53-mediated tumor regression. Dubrez L, Coll JL, Hurbin A, de Fraipont F, Lantejoul S, Favrot MC. Gene Ther; 2001 Nov 15; 8(22):1705-12. PubMed ID: 11892838 [Abstract] [Full Text] [Related]
20. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer. Maemondo M, Saijo Y, Narumi K, Kikuchi T, Usui K, Tazawa R, Matsumoto K, Nakamura T, Sasaki K, Takahashi M, Niitsu Y, Nukiwa T. Cancer Res; 2004 Jul 01; 64(13):4611-20. PubMed ID: 15231673 [Abstract] [Full Text] [Related] Page: [Next] [New Search]